MoonRISe-3: a phase 3 study of erda-iDRS, an erdafitinib intravesical drug-releasing system, vs intravesical chemotherapy in patients with bacillus Calmette-Guérin–treated high-risk non–muscle-invasive bladder cancer with susceptible FGFR alterations
Sunday, May 17, 2026 9:48 AM to 9:56 AM · 8 min. (America/New_York)
Hall B, The Square, Learning Lab
Detail
Oncology: Bladder
Registered attendees
Fernando Alberca Del Arco
Uro-Oncologist, Robotic Surgeon.Hospital Universitario Virgen de la Victoria
Ricardo Rendon
Professor of UrologyDalhousie University And Queen Elizabeth II Health sciences centre
Seth Lerner
Vice Chair for Faculty AffairsBaylor College of Medicine Scott Department of Urology